Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 22, 2024 2:00 PM 3 min read

Federal Rescheduling Is 'Not Enough,' Says Industry Executive, Policy Change Urgently Needed

by Abbey Higginbotham Benzinga Staff Writer
Follow

As federal cannabis rescheduling looms, many in the industry are cautiously optimistic about the potential impact. Michael DeGiglio, CEO of Village Farms, says the changes could be just the beginning of the road to meaningful reform.

DeGiglio, who spoke during an interview at the recent Benzinga Cannabis Capital Conference, shared his thoughts on the challenges the cannabis industry faces despite the possibility of cannabis being moved to a Schedule III classification. While he acknowledged the potential benefits, particularly in reducing the cost of debt and access to capital, DeGiglio expressed frustration over the lack of progress in federal policy.

"No Policy Movement for Four Years"

Reflecting on the current state of cannabis reform, DeGiglio didn’t mince words. "It's been a disaster, in my opinion, four years of really no policy movement whatsoever," he said.

Despite operating one of the largest cannabis cultivation facilities in the world, Village Farms — like many other cannabis companies in the U.S. — is still unable to participate in the domestic market due to federal restrictions fully. The company, based in the U.S., has been forced to focus its efforts abroad, particularly in Canada and Europe, where cannabis laws are more favorable.

Who Will Regulate Cannabis?

DeGiglio pointed out that even if cannabis is moved to Schedule III, many uncertainties remain: "Who’s going to regulate cannabis in the U.S.? Is it going to be the FDA? Where's that funding going to come from? Is Congress going to be involved?"

These questions, according to DeGiglio, are critical to the future of the industry, as the regulatory framework for cannabis in the U.S. is far from settled.

Banking and Financial Challenges

One of the most immediate impacts of rescheduling would be on cannabis businesses’ access to capital. DeGiglio noted that many multi-state operators (MSOs) are struggling financially, with some reportedly unable to pay their IRS tax bills.

"I think many companies need it," he said, referring to the tax relief with a Schedule III designation. He also emphasized that larger companies, particularly those already cash flow positive, would benefit the most from these changes.

Long-Term Optimism Despite Frustration

Despite the challenges, DeGiglio remains committed to the cannabis industry and its future. "I'm all in, and I'm still the largest shareholder of Village Farms," he said, expressing optimism about the business’s medium- to long-term prospects.

While rescheduling cannabis would be a positive first step, DeGiglio argues that much more needs to be done to create a viable and sustainable cannabis market in the U.S. The road ahead is filled with regulatory and financial hurdles, but for leaders such as DeGiglio, the potential rewards make the challenges worth facing.


Don't miss your chance to be part of Cannabis Market Spotlight: California in Anaheim on Nov. 12. Whether you want to connect with industry leaders, explore investment opportunities, or gain the latest insights into California's cannabis market, this event has it all. Secure your spot today!

Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. You can't afford to miss out if you're serious about the business.

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
CannabisEventsExclusivesInterviewExpert IdeasMichael DeGiglioStories That Matter
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...